Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) Apre una nuova scheda del browser
(2015)
Inizio contenuto principale del sito
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)